INSM
Insmed Inc

2,939
Mkt Cap
$41.64B
Volume
1.9M
52W High
$212.75
52W Low
$60.40
PE Ratio
-31.87
INSM Fundamentals
Price
$197.01
Prev Close
$195.24
Open
$195.00
50D MA
$184.18
Beta
0.83
Avg. Volume
2.78M
EPS (Annual)
-$5.57
P/B
44.29
Rev/Employee
$286,158.14
Loading...
Loading...
News
all
press releases
Maverick Capital Ltd. Purchases 379,008 Shares of Insmed, Inc. $INSM
Maverick Capital Ltd. lifted its position in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 89.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
California Public Employees Retirement System Trims Stake in Insmed, Inc. $INSM
California Public Employees Retirement System lessened its position in Insmed, Inc. (NASDAQ:INSM - Free Report) by 16.3% in the second quarter, according to the company in its most recent filing with...
MarketBeat·22h ago
News Placeholder
Insmed, Inc. $INSM Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. cut its holdings in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 43.7% during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·22h ago
News Placeholder
Insmed (NASDAQ:INSM) Given New $269.00 Price Target at TD Cowen
TD Cowen raised their price objective on shares of Insmed from $231.00 to $269.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
Insmed, Inc. $INSM Shares Acquired by Nebula Research & Development LLC
Nebula Research & Development LLC boosted its stake in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 985.0% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
HighVista Strategies LLC Reduces Stake in Insmed, Inc. $INSM
HighVista Strategies LLC cut its stake in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 45.9% during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound?
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·3d ago
News Placeholder
Stempoint Capital LP Sells 25,481 Shares of Insmed, Inc. $INSM
Stempoint Capital LP lessened its position in Insmed, Inc. (NASDAQ:INSM - Free Report) by 29.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·3d ago
News Placeholder
Resolute Capital Asset Partners LLC Makes New Investment in Insmed, Inc. $INSM
Resolute Capital Asset Partners LLC purchased a new position in Insmed, Inc. (NASDAQ:INSM - Free Report) during the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·4d ago
News Placeholder
Hsbc Holdings PLC Has $1.30 Million Stake in Insmed, Inc. $INSM
Hsbc Holdings PLC reduced its position in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 39.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·4d ago

Latest INSM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.